Amneal Pharmaceuticals, Inc.AMRXEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products. The company is headquartered in Bridgewater, New Jersey, and is one of the largest manufacturers of generic drugs in the United States.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| Tushar Patel | 17.40% | 53.6M | ▼ -0.10pp | 2024-05-13 |
| Dipan Patel | 8.80% | 26.9M | ▼ -6.10pp | 2023-11-08 |
| Akram Mahesh | 8.80% | 26.9M | ▼ -1.10pp | 2024-11-14 |
| Chintu Patel | 8.30% | 25.3M | ▼ -8.11pp | 2023-11-08 |
| Chirag Patel | 7.10% | 21.8M | flat | 2024-10-31 |
| The Vanguard Group | 4.45% | 13.6M | — | 2024-02-13 |
| Ambient Impact | 2.40% | 7.6M | ▼ -3.00pp | 2024-04-24 |
| Gautam Patel | 0.07% | 2.0M | ▼ -11.03pp | 2024-01-03 |
Insider Transactions
Net 90d: +$0 · buys $0 / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-04 | Daly Jason B. | EVP, Chief Legal Officer | Option exercise | 35.9K | — | — |
| 2026-03-04 | Chintu Patel | Co-CEO | Option exercise | 92.6K | — | — |
| 2026-03-04 | BOYER ANDREW S | Executive Vice President | Option exercise | 38.2K | — | — |
| 2026-03-04 | Tasos Konidaris | Executive Vice President & CFO | Option exercise | 44.0K | — | — |
| 2026-03-04 | Nikita Shah | Executive Vice President | Option exercise | 35.9K | — | — |
| 2026-03-04 | Patel Chirag K. | President & Co-CEO | Option exercise | 92.6K | — | — |
| 2026-03-03 | Daly Jason B. | EVP, Chief Legal Officer | Option exercise | 22.6K | — | — |
| 2026-03-03 | Daly Jason B. | EVP, Chief Legal Officer | Option exercise | 38.2K | — | — |
| 2026-03-03 | Daly Jason B. | EVP, Chief Legal Officer | Option exercise | 24.3K | — | — |
| 2026-03-03 | Daly Jason B. | EVP, Chief Legal Officer | Option exercise | 305.8K | — | — |
1–10 of 26
Page 1 / 3